Sartorius (SRT3) Given a €76.00 Price Target by Commerzbank Analysts

Commerzbank set a €76.00 ($90.48) target price on Sartorius (FRA:SRT3) in a report published on Wednesday. The brokerage currently has a neutral rating on the stock.

Other research analysts have also issued reports about the company. Berenberg Bank set a €85.00 ($101.19) price target on Sartorius and gave the company a buy rating in a research report on Tuesday, October 17th. Nord/LB set a €70.00 ($83.33) price target on Sartorius and gave the company a sell rating in a research report on Tuesday, October 17th. Kepler Capital Markets set a €64.00 ($76.19) price target on Sartorius and gave the company a neutral rating in a research report on Tuesday, October 17th. Deutsche Bank set a €80.00 ($95.24) price target on Sartorius and gave the company a neutral rating in a research report on Friday, December 1st. Finally, set a €78.00 ($92.86) price target on Sartorius and gave the company a neutral rating in a research report on Thursday, October 26th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Sartorius has an average rating of Hold and an average target price of €78.40 ($93.33).

Sartorius (FRA SRT3) opened at €88.00 ($104.76) on Wednesday. The firm has a market capitalization of $6,450.00 and a price-to-earnings ratio of 71.54. Sartorius has a 52-week low of €63.72 ($75.86) and a 52-week high of €94.00 ($111.90).

ILLEGAL ACTIVITY NOTICE: This report was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.com-unik.info/2018/01/13/sartorius-srt3-given-a-76-00-price-target-by-commerzbank-analysts.html.

About Sartorius

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit